<DOC>
	<DOCNO>NCT02864355</DOCNO>
	<brief_summary>The objective prospective , randomize control study ascertain whether perioperative use FloTrac device guide fluid vasopressor management esophagectomy improve patient outcome . The primary outcome cardiopulmonary complication ; however , secondary outcome decrease patient morbidity ( acute renal injury , anastomotic leak , overall length ICU ( intensive care unit ) hospital stay .</brief_summary>
	<brief_title>Does Perioperative Goal Directed Therapy Using Flotrac Improve Outcomes Esophagectomy Patients</brief_title>
	<detailed_description />
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>Patients 18 year age old Patients undergo primary resection esophageal cancer resultant esophagectomy . Patients &lt; 55kg &gt; 140 kg , base literature regard accuracy FloTrac . Patients sustain preoperative dysrhythmias , base literature regard accuracy FloTrac ( atrial flutter and/or atrial fibrillation ) . Patients diagnose NYHA class IIIIV failure document EF &lt; 30 % Patients unable/unwilling consent study procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>